Sue Stephens - Concepedia

Author

Sue Stephens

UCB Pharma (United Kingdom)ORCID

Also Known As

S Stephens, S. STEPHENS, S. Stephens, S.J. Stephens, STEPHENS, S., SUE STEPHENS, Stephanie Stephens, Sue Stephens

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (United Kingdom)St Bartholomew's Hospital CTI BioPharma (United Kingdom)University of Liverpool University of California, Los Angeles

About

Sue Stephens is an author at UCB Pharma (United Kingdom) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.8K
2	Public Health	2	2	37
3	Allergy	2	2	135
4	Engineering	1	1	37
5	Biomedical Engineering	1	1	37

Sue Stephens

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation Christian Braegger, Stephen J. Nicholls, Simon Murch, The Lancet InflammationIntestinal InflammationMucosal ImmunologyImmunologyHistopathology	1992	694
Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents Andrew Nesbitt, Gianluca Fossati, Marianne Bergin, Inflammatory Bowel Diseases	2007	465
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis Charles J. Fisher, Steven M. Opal, Jean-François Dhainaut, Critical Care Medicine	1993	431
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert, Blood	2003	354
Significance of systemic endotoxaemia in inflammatory bowel disease. Keith Gardiner, M I Halliday, G R Barclay, Gut	1995	232
Anti-TNF therapy inhibits fever in cerebral malaria Dominic Kwiatkowski, M E Molyneux, Sue Stephens, QJM Murine Monoclonal AntibodyAnti-tnf Therapy InhibitsTumour Necrosis FactorMalaria FeverAfrican Trypanosomiasis	1993	203
Monoclonal antibody to TN F in severe septic shock Andrew Exley, J. Cohen, Wim A. Buurman, The Lancet Clinical ImmunologyImmunologyInflammatory MarkerSepsisImmunotherapy	1990	201
CDP571, a humanized antibody to human tumor necrosis factor-alpha Jean-François Dhainaut, Jean‐Louis Vincent, Christian Richard, Critical Care Medicine	1995	150
Treatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571 R.C. Evans, Lane L. Clarke, Patricia K. Heath, Alimentary Pharmacology & Therapeutics	1997	132
Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. Sue Stephens, Spencer Emtage, Olivia M. Vetterlein, PubMed ImmunologyImmunoeditingPathologyImmunophenotypingPharmacotherapy	1995	124

Page 1